BackTelomir Pharmaceuticals Overview

Telomir Pharmaceuticals Total Current Liabilities

Track Telomir Pharmaceuticals's total current liabilities ($240K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$236746.00
↓ 44.01% YoYΔ $-186061.00 vs prior year quarter

Peer trimmed avg / median

Loading

Telomir Pharmaceuticals Total Current Liabilities History

Loading

Telomir Pharmaceuticals vs. peers: Total Current Liabilities Comparison

Loading

Telomir Pharmaceuticals Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Telomir Pharmaceuticals (TELO) FAQ

Telomir Pharmaceuticals (TELO) currently reports a total current liabilities of $240K as of September 2026. That compares with $420K in the prior-year period — down 44.0% year over year. Use the charts on this page to explore Telomir Pharmaceuticals's total current liabilities history and peer comparisons.

Telomir Pharmaceuticals's total current liabilities decreased from $420K to $240K — a 44.0% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Telomir Pharmaceuticals reported $240K in total current liabilities as of September 2026. That compares with $420K in the prior-year period — down 44.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $240K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Telomir Pharmaceuticals, and consider following TELO for alerts when major investors trade the stock.